Free Trial

Avanos Medical (AVNS) Earnings Date, Estimates & Call Transcripts

Avanos Medical logo
$10.78 +0.04 (+0.33%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$10.81 +0.04 (+0.32%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Avanos Medical Earnings Summary

Avanos Medical released Q2 2025 earnings on August 5, 2025, reporting an EPS of $0.17, which missed analysts' consensus estimates of $0.18 by $0.01. Quarterly revenue was reported to be $175 million, above analyst estimates of $165.50 million. With a trailing EPS of -$10.07, Avanos Medical's earnings are expected to grow 31.06% next year, from $1.32 to $1.73 per share.

Latest Q2
Earnings Date
Aug. 5Estimated
Consensus EPS
(Aug. 5)
$0.18
Actual EPS
(Aug. 5)
$0.17 Missed By -$0.01
Actual Revenue
(Aug. 5)
$175.00M

Q2 2025 Earnings Resources

Get Avanos Medical Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avanos Medical and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AVNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avanos Medical Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q1 20251$0.19$0.19$0.19
Q2 20251$0.18$0.18$0.18
Q3 20251$0.19$0.19$0.19
Q4 20251$0.29$0.29$0.29
FY 2025 4 $0.85 $0.85 $0.85
Q1 20261$0.24$0.24$0.24
Q2 20261$0.24$0.24$0.24
Q3 20261$0.30$0.30$0.30
Q4 20261$0.38$0.38$0.38
FY 2026 4 $1.16 $1.16 $1.16
Q1 20271$0.35$0.35$0.35

Avanos Medical Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025$0.18$0.17 -$0.01-$1.66$165.50M$175.00M
5/6/2025Q1 2025$0.19$0.26+$0.07$0.14$161.75M$167.50M
2/26/2025Q4 2024$0.40$0.43+$0.03-$8.64$177.23M$179.60M
7/31/2024Q2 2024$0.29$0.34+$0.05$0.64$170.67M$171.70M
5/2/2024Q1 2024$0.21$0.19 -$0.02$0.40$162.90M$166.10M
2/20/2024Q4 2023$0.37$0.36 -$0.01$0.49$170.43M$173.30M
11/1/2023Q3 2023$0.29$0.30+$0.01$0.68$169.60M$171.30M
8/9/2023Q2 2023$0.34$0.24 -$0.10$1.94$186.30M$169.40M

Avanos Medical Earnings - Frequently Asked Questions

Avanos Medical (NYSE:AVNS) last announced its quarterly earning data on Tuesday, August 5, 2025. Learn more on AVNS's earnings history.

Avanos Medical updated its FY 2025 earnings guidance on Tuesday, August, 5th. The company provided EPS guidance of 0.750-0.950 for the period, compared to the consensus earnings per share estimate of 0.850. The company issued revenue guidance of $665.0 million-$685.0 million, compared to the consensus revenue estimate of $672.0 million.

In the previous quarter, Avanos Medical (NYSE:AVNS) missed the analysts' consensus estimate of $0.18 by $0.01 with a reported earnings per share (EPS) of $0.17. Learn more on analysts' earnings estimate vs. AVNS's actual earnings.

The conference call for Avanos Medical's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Avanos Medical's latest earnings report can be read online.
Read Transcript

Avanos Medical (NYSE:AVNS) has a recorded annual revenue of $687.80 million.

Avanos Medical (NYSE:AVNS) has a recorded net income of -$392.10 million. AVNS has generated -$10.07 earnings per share over the last four quarters.

Avanos Medical's earnings are expected to grow from $1.32 per share to $1.73 per share in the next year, which is a 31.06% increase.

More Earnings Resources from MarketBeat



This page (NYSE:AVNS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners